Covovax gets nod as booster dose
The drug regulator has approved Covovax as a heterologous booster dose for adults administered with two doses of Covishield or Covaxin, sources said.
By ET Bureau | Updated:
The drug regulator has approved Covovax as a heterologous booster dose for adults administered with two doses of Covishield or Covaxin, sources said.
Start a SIP with as low as ₹500 with ET Money App!
Download
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
Related Articles
Current Covid strain mild, SII has produced 5-6 million Covovax doses: Adar Poonawalla2023-04-22T17:23:57Z- Covid jab Covovax as heterologous booster to be available on CoWIN soon; to cost Rs 225 per dose2023-04-10T11:43:47Z
- Serum Institute seeks inclusion of Covovax on CoWIN as heterologous booster dose for adults2023-04-03T12:06:29Z
ADVERTISEMENT
